The impact of obesity in electromyographic neuromuscular monitoring.

The impact of obesity in electromyographic neuromuscular monitoring. - The impact of obesity in electromyographic neuromuscular monitoring.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054036

Enrollment

Registered

2024-04-02

Start date

2024-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with BMI > 30 and BMI 18.5-24.9

Exclusion criteria

Exclusion criteria: Patient with neuromuscular disease, patient with ASA 4, 5, 6 (except obesity)

Design outcomes

Primary

Measure	Time frame
Supramaximal current	—

Secondary

Measure	Time frame
compound muscle action potential, impossible measurement, distance from skin surface to abductor digiti minimi muscle, distance from skin surface to ulnar nerve, baseline TOF ratio, final TOF ratio	—

Countries

Japan

Contacts

Public ContactHajime Iwasaki

Asahikawa Medical University Department of Anesthesiology

iwasakih@asahikawa-med.ac.jp0166-68-2583

Outcome results